man measuring waist

NICE recommend new weight loss jab

NICE have recommended a new drug which could benefit thousands suffering with obesity and help them to lose weight.

The drug known as semaglutide, can be used in adults with at least one weight related condition and a BMI of at least 35kg/m2 and in exceptional circumstance those with a BMI of 30.0kg/m2 to 24.9kg/m2

Semaglutide can only be prescribed for a maximum of two year and must be used as part of a weight management programme such as a tier 3 weight management programme or tier 4 speciality obesity services.

The results of the initial clinical trial found that participants taking semaglutide lost on average 12 percent more of their body weight compared to those taking the placebo.

The drug should be injected once a week using a pre-filled pen, similar to that used to in administering insulin in diabetes patients.

The injection works by supressing appetite and mimicking glucagon-like-peptide-1 (GLP1), a hormone released after eating.

Helen Knight, programme director in the centre for health technology evaluation at NICE, said: “We know that management of overweight and obesity is one of the biggest challenges our health service is facing with nearly two thirds of adults either overweight or obese. It is a lifelong condition that needs medical intervention, has psychological and physical effects, and can affect quality of life.

“But in recent years NICE has been able to recommend a new line of pharmaceutical treatments which have shown that those people using them, alongside changes to their diet and exercise, have been able to reduce their weight.”

The list price for a pack of four semaglutide pre-filled pens (0,24mg, 0.5mg and 1.0mg) is £73.25 (excluding VAT).and could drastically reduce costs for weight-related issues on the NHS.

Currently it costs the NHS an estimated £6.1 billion for treatments related to obesity in the UK, with an estimated 28 percent of adults in England being obsese and a further 36 percent being overweight.

A consultation has begun to make comments on the recommendations, which can be made here before 5pm on Tuesday 1st March 2022.

NHE Nov/Dec 2023

NHE Nov/Dec 2023

AI is key in helping dementia patients live independently for longer.

The Nov/Dec 2023 edition of NHE brings you expert comment and analysis on a range of key health sector topics, from digital transformation to navigating post-pandemic challenges.

Videos...

View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Events

NHE has created a full calendar of events to address the most important issues that influence the delivery of healthcare services. Over 365 days you'll have the opportunity to hear from a range of highly motivating, informative and inspirational speakers. These speakers will equip you with the knowledge and unique insight to enable you to overcome the challenges that you face.

National Health Executive Podcast

Ep 39.
What makes a good NHS manager? with Anthony Painter, Director of Policy at Chartered Management Institute (CMI)

In episode 39 of the National Health Executive podcast, we were joined by Anthony Painter, who is the director of policy at the Chartered Management Institute (CMI), to discuss all things management within the UK health sector and NHS.
 

During the podcast, Anthony shared some of the recent research CMI conducted in partnership with the Social Market Foundation, which centred around the state of management and leadership within the NHS.

More articles...

View all